About
Uniqure Nv (NASDAQ:QURE) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 2 2026
uniQure Announces 2025 Financial Results and Provides Recent Company Updates
Feb 23 2026
uniQure to Announce 2025 Financial Results
Feb 6 2026
uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
Jan 9 2026
uniQure Announces Type A Meeting Scheduled with FDA
Dec 4 2025
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
Financials
Revenue
$16.1 M
Market Cap
$1.07 B
EPS
-3.46
Translate